Clinical trial
An Open-label Study to Evaluate Topiramate Therapy in Migraine Patients, and Its…
NCT00261469 · Janssen-Ortho Inc., Canada, Industry · Completed
Key facts
| NCT number | NCT00261469 |
|---|---|
| Title | An Open-label Study to Evaluate Topiramate Therapy in Migraine Patients, and Its Effects on Subject Responsiveness to Migraine Treatment With Triptans |
| Official title | Efficacy of Topiramate Prophylaxis as add-on to Triptan Therapy for Migraine |
| Lead sponsor | Janssen-Ortho Inc., Canada, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Headache |
| Intervention type | Drug |
| Interventions | topiramate |
| Enrollment | 38 |
| Start date | Apr 1, 2003 |
| Completion | Nov 1, 2004 |
| First posted | Dec 5, 2005 |
| Last update posted | May 17, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: